In cancer research, HSF4 can promote EMT in liver cancer cells to stimulate cell proliferation and invasion and was associated with poor prognosis in COAD patients (P. Ma et al., 2020; Y. Yang et al., 2017). This evidence concerns the gene HSF4 and colon adenocarcinoma.